热消融在肝癌免疫治疗中的研究进展
刘晓琳， 孔凡创， 王晓光， 宋政炜， 徐锋 - 中国肿瘤临床, 2018 - cjco.cn
… It can not only directly inactivate tumor cells, but also induce specific antitumor immunity. …
Erratum: Inflammation-induced IgA(+) cells dismantle anti-liver cancer immunity[J]. Nature, 2017…
Erratum: Inflammation-induced IgA(+) cells dismantle anti-liver cancer immunity[J]. Nature, 2017…
人体肠道微生态与肝脏免疫关系研究进展
吴永娜， 张磊， 陈拓， 李汛， 刘光琇 - 中国微生态学杂志, 2021 - cjm.dmu.edu.cn
… immunity. This paper reviews the correlation between intestinal microecology and liver immunity,
in … to provide a scientific basis for the study on human microecology and liver immunity. …
in … to provide a scientific basis for the study on human microecology and liver immunity. …
鼻咽癌同步放化疗前后炎性指标变化及预测价值
范黎， 黎越， 徐细明 - 山东大学耳鼻喉眼学报, 2021 - ebhyxbwk.njournal.sdu.edu.cn
… Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity[J]. Nature, 2017, 551(…
used for the detection of cell cycle stages in DAPT-treated 5-8F / CDDP cells. Finally, western …
used for the detection of cell cycle stages in DAPT-treated 5-8F / CDDP cells. Finally, western …
[HTML][HTML] 肠道微生物在慢性肝病中的作用及其潜在治疗策略
时行， 曹玉珠， 丁语石， 祝娉婷， 李晓曼， 吴媛媛… - 2020 - html.rhhz.net
… receptor,PIGR)能够调节IgA向肠腔的转运并维持微生物群的稳态.Shalapour等 [18] 研究发现
,在NASH诱导PIGR敲除小鼠的HCC模型中,全身和肝脏IgA水平升高以及肝脏肿瘤发生率增加.此外…
,在NASH诱导PIGR敲除小鼠的HCC模型中,全身和肝脏IgA水平升高以及肝脏肿瘤发生率增加.此外…
[HTML][HTML] 术前外周血炎性指标联合糖蛋白抗原19-9 对结肠癌早期诊断及预后评估的价值
叶序卷， 姚兰， 刘世呈， 戴红梅 - 中华普通外科学文献 …, 2019 - zhptwkxwx.cma-cmc.com.cn
… The position of neutrophils-to-lymphocytes and lymphocytes-to-platelets ratio as predictive
markers of progression and prognosis in patients with non-small cell lung cancer[J]. Open …
markers of progression and prognosis in patients with non-small cell lung cancer[J]. Open …
淋巴细胞活化基因3 在肝脏相关疾病中的研究进展.
陈锐， 王志鑫， 樊海宁， 王海久 - Journal of Clinical …, 2021 - search.ebscohost.com
… This article summarizes the research advances in the role of the new immune checkpoint …
Author correction: Inflammation - induced IgA + cells dismantle anti - liver cancer immunity[ J…
Author correction: Inflammation - induced IgA + cells dismantle anti - liver cancer immunity[ J…
[HTML][HTML] 非酒精性脂肪性肝病相关肝细胞癌的研究进展
田昊宇， 关琳 - 中国医科大学学报, 2022 - html.rhhz.net
… IgA + 细胞在NASH中累积可抑制CD8 + T细胞,从而促进HCC的发生 [16] .最近研究 [17] 表明
,CD36-Nogo-B-YAP途径重新编程了oxLDL代谢,促进脂噬,导致溶血磷脂酸增强YAP致癌活性,并…
,CD36-Nogo-B-YAP途径重新编程了oxLDL代谢,促进脂噬,导致溶血磷脂酸增强YAP致癌活性,并…
[PDF][PDF] 非酒精性脂肪性肝病与相关肝细胞肝癌研究进展
王玉洁 - 中国医学创新, 2020 - zgyxcx.com
… Inflammationinduced IgA+ cells dismantle anti-liver cancer immunity[J]. Nature,2017,551(…
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease …
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease …
乙型肝炎肝硬化患者并发急性肾损伤危险因素分析
韩成美， 韩永峰， 王春华 - 实用肝脏病杂志, 2021 - manu43.magtech.com.cn
… Inflammation - induced IgA+ cells dismantle anti-liver cancer immunity. Nature, 2017,551 (…
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines …
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines …
[HTML][HTML] 肝硬化患者肝外肿瘤的发病风险及治疗措施
王硕， 郭晓钟， 徐士雪， 祁兴顺 - 世界华人消化杂志, 2020 - wjgnet.com
… Additionally, the management of non-hepatic cancers in cirrhotic patients is a clinical …
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature. 2017;551:340…
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature. 2017;551:340…